These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28267255)

  • 1. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
    Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
    Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline quality of life predicts pelvic exenteration outcome.
    Choy I; Young JM; Badgery-Parker T; Masya LM; Shepherd HL; Koh C; Heriot AG; Solomon MJ
    ANZ J Surg; 2017 Nov; 87(11):935-939. PubMed ID: 26687437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of life after extensive pelvic surgery].
    Levý M; Lipská L; Visokai V; Šimša J
    Rozhl Chir; 2016; 95(9):358-462. PubMed ID: 27653304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
    Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
    Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
    Williams M; Perera M; Nouhaud FX; Coughlin G
    Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
    Palma CA; van Kessel CS; Solomon MJ; Leslie S; Jeffery N; Lee PJ; Austin KKS
    Eur J Surg Oncol; 2023 Jul; 49(7):1250-1257. PubMed ID: 36658054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
    Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
    van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
    van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
    Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life of survivors after pelvic exenteration for rectal cancer.
    Austin KK; Young JM; Solomon MJ
    Dis Colon Rectum; 2010 Aug; 53(8):1121-6. PubMed ID: 20628274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total pelvic exenteration for locally advanced rectal cancer.
    Law WL; Chu KW; Choi HK
    J Am Coll Surg; 2000 Jan; 190(1):78-83. PubMed ID: 10625236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.